Trial site
University of Minnesota Medical Center
- 14running trials
- 7closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Aortic stenosis4 trials
- Fabry disease2 trials
- Prostate cancer2 trials
- Chronic kidney disease1 trial
- Congenital heart disease1 trial
- Coronary artery disease1 trial
- Cystic fibrosis1 trial
- Diffuse large B-cell lymphoma1 trial
- Haemophagocytic lymphohistiocytosis1 trial
- HIV1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- and 2 more
- Phase
- Phase 35 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting7 trials
- Completed5 trials
- Active, not recruiting4 trials
- Not yet recruiting2 trials
- Withdrawn2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Edwards Lifesciences3 trials
- Janssen Research & Development, LLC2 trials
- National Institute of Allergy and Infectious Diseases (NIAID)2 trials
- Sangamo Therapeutics2 trials
- University of Minnesota2 trials
- and 10 more
Running trials
Not yet recruiting
Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant.
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Active, not recruiting
Long-Term Follow-up of Subjects Who Were Treated With ST-920
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Aortic stenosis1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Completed
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Completed
Recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026